Todd Pillion
- Republican
- Senator
- District 6
Primary
Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin.
Approved by Governor-Chapter 214 (effective 7/1/19)
Enrolled Bill communicated to Governor on February 19, 2019
Governor's Action Deadline Midnight, March 26, 2019
Signed by President
Signed by Speaker
Enrolled
Placed on Calendar
Senate substitute agreed to by House 19106567D-S1 (97-Y 0-N)
Committee substitute agreed to 19106567D-S1
Read third time
Reading of substitute waived
Engrossed by Senate - committee substitute HB2557S1
Constitutional reading dispensed
Referred to Committee on Education and Health
Read third time and passed House BLOCK VOTE (99-Y 0-N)
Read second time and engrossed
Read first time
Prefiled and ordered printed; offered 01/09/19 19101661D
Referred to Committee on Health, Welfare and Institutions
| Bill Text Versions | Format |
|---|---|
| House: Prefiled and ordered printed; offered 01/09/19 19101661D | HTML |
| Senate: Committee substitute printed 19106567D-S1 | HTML |
| House: Bill text as passed House and Senate (HB2557ER) | HTML |
| Governor: Acts of Assembly Chapter text (CHAP0214) | HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.